Morton Glanz

566 total citations
9 papers, 423 citations indexed

About

Morton Glanz is a scholar working on Surgery, Rehabilitation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Morton Glanz has authored 9 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Rehabilitation and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Morton Glanz's work include Stroke Rehabilitation and Recovery (3 papers), Opioid Use Disorder Treatment (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Morton Glanz is often cited by papers focused on Stroke Rehabilitation and Recovery (3 papers), Opioid Use Disorder Treatment (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Morton Glanz collaborates with scholars based in United States. Morton Glanz's co-authors include Sidney Klawansky, Thomas C. Chalmers, Catherine S. Berkey, William B. Stason, David L. McClure, John E. Hokanson, Robert J. Valuck, James R. Murphy and Nirav Shah and has published in prestigious journals such as Annals of Internal Medicine, Journal of Clinical Epidemiology and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Morton Glanz

9 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morton Glanz United States 8 208 133 103 87 80 9 423
R.S. MacWalter United Kingdom 8 131 0.6× 26 0.2× 55 0.5× 45 0.5× 42 0.5× 13 373
Philippe Rossier Switzerland 6 119 0.6× 32 0.2× 187 1.8× 84 1.0× 43 0.5× 12 392
Claude Vaney Switzerland 11 57 0.3× 45 0.3× 178 1.7× 96 1.1× 79 1.0× 17 672
John W. Dunne Australia 14 46 0.2× 38 0.3× 163 1.6× 149 1.7× 37 0.5× 30 468
Bryant A. Seamon United States 9 78 0.4× 47 0.4× 61 0.6× 31 0.4× 34 0.4× 26 331
Cíntia Ehlers Botton Brazil 13 81 0.4× 224 1.7× 58 0.6× 13 0.1× 26 0.3× 39 857
Shinichi Shimada Japan 15 264 1.3× 20 0.2× 160 1.6× 71 0.8× 141 1.8× 42 615
J.M. Rijkelijkhuizen Netherlands 14 25 0.1× 114 0.9× 26 0.3× 21 0.2× 81 1.0× 21 706
Hye Jin Lee South Korea 12 62 0.3× 35 0.3× 35 0.3× 26 0.3× 46 0.6× 24 367
Jeffrey Metter United States 9 54 0.3× 21 0.2× 49 0.5× 19 0.2× 66 0.8× 12 467

Countries citing papers authored by Morton Glanz

Since Specialization
Citations

This map shows the geographic impact of Morton Glanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morton Glanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morton Glanz more than expected).

Fields of papers citing papers by Morton Glanz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morton Glanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morton Glanz. The network helps show where Morton Glanz may publish in the future.

Co-authorship network of co-authors of Morton Glanz

This figure shows the co-authorship network connecting the top 25 collaborators of Morton Glanz. A scholar is included among the top collaborators of Morton Glanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morton Glanz. Morton Glanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
McClure, David L., Robert J. Valuck, Morton Glanz, James R. Murphy, & John E. Hokanson. (2007). Statin and statin–fibrate use was significantly associated with increased myositis risk in a managed care population. Journal of Clinical Epidemiology. 60(8). 812–818. 49 indexed citations
2.
McClure, David L., Robert J. Valuck, Morton Glanz, & John E. Hokanson. (2006). Systematic review and meta‐analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiology and Drug Safety. 16(2). 132–143. 39 indexed citations
3.
Glanz, Morton, Sidney Klawansky, & Thomas C. Chalmers. (1997). Biofeedback therapy in stroke rehabilitation: a review. Journal of the Royal Society of Medicine. 90(1). 33–39. 30 indexed citations
4.
Glanz, Morton, et al.. (1997). Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.. PubMed. 6(4). 339–49. 24 indexed citations
5.
Glanz, Morton, et al.. (1997). Methadone vs. L-alpha-acetylmethadol (LAAM) in the Treatment of Opiate Addiction:A Meta-Analysis of the Randomized, Controlled TriaIs. American Journal on Addictions. 6(4). 339–349. 9 indexed citations
6.
Glanz, Morton, et al.. (1997). Methadone vs. L‐alpha‐acetylmethadol (LAAM) in the Treatment of Opiate Addiction. American Journal on Addictions. 6(4). 339–349. 19 indexed citations
7.
Glanz, Morton, Sidney Klawansky, William B. Stason, Catherine S. Berkey, & Thomas C. Chalmers. (1996). Functional electrostimulation in poststroke rehabilitation: A meta-analysis of the randomized controlled trials. Archives of Physical Medicine and Rehabilitation. 77(6). 549–553. 198 indexed citations
8.
Glanz, Morton, et al.. (1995). Biofeedback therapy in poststroke rehabilitation: A meta-analysis of the randomized controlled trials. Archives of Physical Medicine and Rehabilitation. 76(6). 508–515. 53 indexed citations
9.
Glanz, Morton. (1975). The Heart in Athletes. Annals of Internal Medicine. 83(4). 574–575. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026